Catheter Precision Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 154/206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 38.00.In the medium term, the stock price is expected to trend down.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Catheter Precision Inc's Score
Industry at a Glance
Industry Ranking
154 / 206
Overall Ranking
466 / 4562
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
38.000
Target Price
+1753.66%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Catheter Precision Inc Highlights
StrengthsRisks
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 2900.00% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 420.00K.
Overvalued
The company’s latest PE is 0.05, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 24.65K shares, decreasing 29.05% quarter-over-quarter.
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
Ticker SymbolVTAK
CompanyCatheter Precision Inc
CEOJenkins (David A)
Websitehttps://www.ramed.com/
FAQs
What is the current price of Catheter Precision Inc (VTAK)?
The current price of Catheter Precision Inc (VTAK) is 1.770.
What is the symbol of Catheter Precision Inc?
The ticker symbol of Catheter Precision Inc is VTAK.
What is the 52-week high of Catheter Precision Inc?
The 52-week high of Catheter Precision Inc is 15.681.
What is the 52-week low of Catheter Precision Inc?
The 52-week low of Catheter Precision Inc is 1.492.
What is the market capitalization of Catheter Precision Inc?
The market capitalization of Catheter Precision Inc is 2.92M.
What is the net income of Catheter Precision Inc?
The net income of Catheter Precision Inc is -21.80M.
Is Catheter Precision Inc (VTAK) currently rated as Buy, Hold, or Sell?
According to analysts, Catheter Precision Inc (VTAK) has an overall rating of --, with a price target of 38.000.
What is the Earnings Per Share (EPS TTM) of Catheter Precision Inc (VTAK)?
The Earnings Per Share (EPS TTM) of Catheter Precision Inc (VTAK) is 36.353.